Further investigations inferred a critical role for Brd4 in MPNST pathogenesis as inhibition by shRNAs or by JQ1, a small molecule BET (bromodomain and extraterminal domain) inhibitor, severely impaired in vitro growth and in vivo tumorigenesis [13]. Here, BRD4 is linked to malignant peripheral nerve sheath tumor.